HOME >> MEDICINE >> NEWS
Newest version of 'the pill' confers same stroke risk as old pill

e with the three generations of oral contraceptives. Of the 203 stroke cases and 925 controls between the ages of 18 and 49, they found the risk of stroke in women taking any type of OC 2.3 times that of women not taking one.

The few women still using the first-generation pill were 1.7 times more likely to have a stroke than women not using any oral birth control. Women taking the third-generation pill had an increased stroke risk 2.2 times that of non-pill users. Those taking the second-generation pill formulations had 2.4 times the risk, says senior author Ale Algra, M.D., associate professor of clinical epidemiology at University Medical Center, Utrecht, Netherlands.

Risk factors for stroke smoking, hypertension, diabetes and high cholesterol appeared to add to the stroke risk in all pill users in the study.

Because there is virtually no difference in the risk of stroke in second- and third- generation pills, the balance of the decision whether to use second- or third- generation oral contraceptives should be determined by the risk of venous thrombosis, blood clots deep in the leg, Algra says.

Last year, Algra and his team linked third-generation OCs with an increased risk of developing blood clots in deep veins of the body (venous thrombosis). In a meta-analysis of previous studies of OCs, the group found a higher risk of venous thrombosis in third generation pills than of second-generation pills. Venous thrombosis usually resolves without complications, but the clots can travel to the lungs, causing a life-threatening pulmonary embolism.

Because of the risk of leg blood clots with third-generation OCs, Algra suggests women use second-generation OCs. Very few women take the first-generation version of the pill.

They seriously should consider using second-generation preparations if they did not use OCs before, or switching from third-generation pills to second-generation pills if they are current users, he stresses.


'"/>

Contact: Carole Bullock or Bridgette McNeill
210-582-7159
American Heart Association
7-Feb-2002


Page: 1 2 3

Related medicine news :

1. Newest Depression Medications Widely Prescribed For Children
2. Supporters of NIH policy see publishers gambit as possible diversion
3. Camera pill promising for diagnosis of small bowel disease
4. Virtual stomach reveals pills path
5. GSA confers 2004 Nathan Shock New Investigator Award to UTHSCs Marciniak
6. The Gerontological Society of America confers 2004 M. Powell Lawton Award to Penn States Zarit
7. GSA confers 2004 Joseph T. Freeman Award to St. Louis Universitys Morley
8. GSA confers 2004 Distinguished Mentorship in Gerontology Award to the Michigans Jackson
9. GSA confers 2004 Richard Kalish Innovative Publication Award to W. Ontarios Connidis and McMullin
10. The Gerontological Society of America confers 2003 Kalish Award to Utahs Pasupathi
11. The Gerontological Society of America confers 2003 Lawton Award to Columbia Universitys Gurland

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Newest version the pill confers same stroke risk old pill

(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... a top review from Clinicians Report of Provo, Utah. The Clinicians Report is ... a selected group of dentists located throughout the U.S. Whiter Image's In-Office whitening ...
(Date:9/3/2015)... ... 2015 , ... James Earl Jones will be hosting an upcoming VOICES IN ... Jones will introduce a segment that discusses why it is important for the workplace ... be fostered in any working environment. , Employers are out billions of dollars year ...
(Date:9/2/2015)... ... 03, 2015 , ... The Aspen Clinic (TAC), located in Basalt, ... kick-starting and inspiring wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, ... mind-body approach to fitness - we are much more than a gym. Our ...
(Date:9/2/2015)... CA (PRWEB) , ... September 02, 2015 , ... The ... genome by using a complex of the Cas9 nuclease with either a chimeric single ... RNA (tracrRNA)). The ability of any given guide RNA (sgRNA or crRNA) to create ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Based in Beverly ... fleet of truly superb luxury vehicles based on which of the latest and greatest ... the latest step forward in pursuit of this goal: a 2015 Rolls Royce ...
Breaking Medicine News(10 mins):Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2
(Date:9/2/2015)... , Sept. 2, 2015 Research and ... of the "Medical Device Studies: Clinical Evidence ... to their offering. This course ... involved in gathering clinical evidence required for medical ... required for all medical devices and the emphasis ...
(Date:9/2/2015)... Sept. 2, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... Chief Financial Officer of Neurocrine Biosciences, will be presenting ... New York City . The live ... ET (8:25am PT).  The presentation will be webcast and ... http://www.neurocrine.com .   Listeners are encouraged to ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/r6wspz/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. Advances in understanding of ... new avenues and possibilities for improved drug delivery ... enzymes, and receptors that control the penetration of ...
Breaking Medicine Technology:Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 2Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Report 2015-2024 3
Cached News: